Dr. Reddy's Laboratories is recalling 4,404 blister packs of Clopidogrel Tablets (300 mg), a medication typically used to prevent blood clots. The recall was initiated because certain lots failed dissolution testing during routine stability checks, meaning the medication may not break down or release properly in the body. This issue could result in the drug being less effective than intended for patients. Consumers who have these tablets should consult their healthcare provider or pharmacist immediately.
If the tablets do not dissolve correctly, the medication may not be fully absorbed into the bloodstream, potentially failing to prevent blood clots or other cardiovascular events as intended.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.